Next-Gen Research & Development
We are discovering and researching a broad range of natural and semi-synthetic compounds, therapies, and technologies with the goal of unlocking new treatments that can significantly improve the quality of life for our patients.
Complex Problems Require Breakthrough Solutions.
Several ventures are engaged in rolling out clinical trials using synthetic psychedelic medicines. Psychedelic compounds are produced in many plants and fungi as part of an extensively evolved and differentiated tryptophan metabolome found through nature. It is for these reasons that the signally pathways in animals can be modulated by natural extracts containing tryptaminergic compounds.
Whilst there is still a lot to be discovered relating to the exact mechanisms of such signalling, studies indicate a host of benefits for vascular, endocrine and immune system health as well as in ageing and inflammatory conditions.
Psilocybin mushrooms are a natural source of tryptamine rich alkaloids that can be readily harnessed through cultivation, extraction and isolation of their active compounds.
Our research and development will be concentrated around setting the standard for all aspects of natural production and extraction of psilocybin and other plant derived tryptamines in order to provision clinical staged trials.
We are collaborating with several Universities and Institutions to further the use of the tryptamines in targeted research on neurological disorders. The continued elucidation of receptor signalling pathways in the human serotonergic and dopaminergic systems will provide insight into how to dose and use the tryptamines as natural modulators of these systems in a range of indications. This understanding is critical to developing drugs to meaningfully transform patients lives who are afflicted by either serious neurological disorders or rare diseases.
Neuromind BioPharma will continue to innovate, develop and patent its own technologies that integrate psychedelic compounds and enhance the therapy potential, and is committed to equipping medical professionals with the resources & technology to improve patient experience and patient outcomes.
